The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(6-Amino-purin-9-yl)-cyclopentane-1,2,3-triol ID: ALA405082
PubChem CID: 469184
Max Phase: Preclinical
Molecular Formula: C10H13N5O3
Molecular Weight: 251.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1C[C@@H](O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C10H13N5O3/c11-9-6-10(13-2-12-9)15(3-14-6)4-1-5(16)8(18)7(4)17/h2-5,7-8,16-18H,1H2,(H2,11,12,13)/t4-,5-,7+,8-/m1/s1
Standard InChI Key: VFKHECGAEJNAMV-HXOWADHMSA-N
Molfile:
RDKit 2D
18 20 0 0 1 0 0 0 0 0999 V2000
-3.2412 -20.1613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5724 -19.6781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8252 -18.8928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6503 -18.8905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9073 -19.6745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2435 -20.9863 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7885 -19.9353 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4980 -18.1373 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4798 -16.8053 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9727 -17.4646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7003 -17.0705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7142 -17.8922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0107 -18.3134 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2928 -17.9140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2827 -17.0890 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9869 -16.6717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9764 -15.8466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6926 -19.9273 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3 4 1 0
4 5 1 0
11 9 1 0
9 10 2 0
10 8 1 0
5 1 1 0
1 2 1 0
11 12 2 0
1 6 1 6
12 13 1 0
13 14 2 0
2 7 1 6
14 15 1 0
2 3 1 0
15 16 2 0
16 11 1 0
3 8 1 1
16 17 1 0
8 12 1 0
5 18 1 6
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 251.25Molecular Weight (Monoisotopic): 251.1018AlogP: -1.56#Rotatable Bonds: 1Polar Surface Area: 130.31Molecular Species: NEUTRALHBA: 8HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.95CX Basic pKa: 3.69CX LogP: -2.25CX LogD: -2.25Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.48Np Likeness Score: 0.93
References 1. Siddiqi SM, Chen X, Schneller SW, Ikeda S, Snoeck R, Andrei G, Balzarini J, De Clercq E.. (1994) An epimer of 5'-noraristeromycin and its antiviral properties., 37 (9): [PMID:8176716 ] [10.1021/jm00035a020 ] 2. Ando T, Kojima K, Chahota P, Kozaki A, Milind ND, Kitade Y.. (2008) Synthesis of 4'-modified noraristeromycins to clarify the effect of the 4'-hydroxyl groups for inhibitory activity against S-adenosyl-L-homocysteine hydrolase., 18 (8): [PMID:18374570 ] [10.1016/j.bmcl.2008.03.029 ]